190 related articles for article (PubMed ID: 34935094)
21. A case-cohort study of the association between adiponectin and mortality in EPIC-Heidelberg: NT-proBNP may explain the adiponectin paradox.
Mukama T; Johnson T; Kaaks R; Katzke V
Nutr Metab Cardiovasc Dis; 2023 Apr; 33(4):853-863. PubMed ID: 36740561
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study).
Everett BM; Ridker PM; Cook NR; Pradhan AD
Am J Cardiol; 2015 Aug; 116(4):532-7. PubMed ID: 26081066
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
Ruff CT; Morrow DA; Jarolim P; Ren F; Contant CF; Kaur A; Curtis SP; Laine L; Cannon CP; Brune K
J Rheumatol; 2011 Jun; 38(6):1071-8. PubMed ID: 21459935
[TBL] [Abstract][Full Text] [Related]
24. N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.
Welsh P; Doolin O; Willeit P; Packard C; Macfarlane P; Cobbe S; Gudnason V; Di Angelantonio E; Ford I; Sattar N
Eur Heart J; 2013 Feb; 34(6):443-50. PubMed ID: 22942340
[TBL] [Abstract][Full Text] [Related]
25. The N-terminal pro B-type natriuretic peptide, and risk of dementia and cognitive decline: a 10-year follow-up study in the general population.
Mirza SS; de Bruijn RF; Koudstaal PJ; van den Meiracker AH; Franco OH; Hofman A; Tiemeier H; Ikram MA
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):356-62. PubMed ID: 25918047
[TBL] [Abstract][Full Text] [Related]
26. N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study.
Bruno G; Landi A; Barutta F; Ghezzo G; Baldin C; Spadafora L; Schimmenti A; Prinzis T; Cavallo Perin P; Gruden G
Diabetes Care; 2013 Sep; 36(9):2677-82. PubMed ID: 23564918
[TBL] [Abstract][Full Text] [Related]
27. Nighttime home blood pressure as a mediator of N-terminal pro-brain natriuretic peptide in cardiovascular events.
Hoshide S; Kanegae H; Kario K
Hypertens Res; 2021 Sep; 44(9):1138-1146. PubMed ID: 34244693
[TBL] [Abstract][Full Text] [Related]
28. Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome.
Karadağ C; Yoldemir T
J Obstet Gynaecol; 2019 Nov; 39(8):1154-1159. PubMed ID: 31215274
[TBL] [Abstract][Full Text] [Related]
29. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
Circulation; 2005 Jul; 112(1):110-6. PubMed ID: 15983245
[TBL] [Abstract][Full Text] [Related]
30. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
31. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.
Doi Y; Ninomiya T; Hata J; Hirakawa Y; Mukai N; Ikeda F; Fukuhara M; Iwase M; Kiyohara Y
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2997-3003. PubMed ID: 21921261
[TBL] [Abstract][Full Text] [Related]
32. Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.
Hao J; Cheang I; Zhang L; Wang K; Wang HM; Wu QY; Zhou YL; Zhou F; Xu DJ; Zhang HF; Yao WM; Li XL
Chin Med J (Engl); 2019 Oct; 132(19):2278-2285. PubMed ID: 31567379
[TBL] [Abstract][Full Text] [Related]
33. N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study.
Wannamethee SG; Welsh P; Whincup PH; Lennon L; Papacosta O; Sattar N
Eur J Heart Fail; 2014 Jan; 16(1):25-32. PubMed ID: 23901058
[TBL] [Abstract][Full Text] [Related]
34. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M
Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261
[TBL] [Abstract][Full Text] [Related]
35. Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
Shlipak MG; Ix JH; Bibbins-Domingo K; Lin F; Whooley MA
Am J Med; 2008 Jan; 121(1):50-7. PubMed ID: 18187073
[TBL] [Abstract][Full Text] [Related]
36. N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Nguyen K; Fan W; Bertoni A; Budoff MJ; Defilippi C; Lombardo D; Maisel A; Szklo M; Wong ND
Am J Cardiol; 2020 Apr; 125(8):1194-1201. PubMed ID: 32106929
[TBL] [Abstract][Full Text] [Related]
37. A Systematic Review and Meta-Analysis of Advanced Biomarkers for Predicting Incident Cardiovascular Disease among Asymptomatic Middle-Aged Adults.
Romero-Cabrera JL; Ankeny J; Fernández-Montero A; Kales SN; Smith DL
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362325
[TBL] [Abstract][Full Text] [Related]
38. Amino-Terminal Pro-B-Type Natriuretic Peptide Improves Discrimination for Incident Atherosclerotic Cardiovascular Disease Beyond Ambulatory Blood Pressure in Elderly Men.
Skoglund PH; Höijer J; Ärnlöv J; Zethelius B; Svensson P
Hypertension; 2015 Sep; 66(3):681-6; discussion 445. PubMed ID: 26150437
[TBL] [Abstract][Full Text] [Related]
39. NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: the Heinz Nixdorf Recall Study.
Kara K; Lehmann N; Neumann T; Kälsch H; Möhlenkamp S; Dykun I; Broecker-Preuss M; Pundt N; Moebus S; Jöckel KH; Erbel R; Mahabadi AA
Int J Cardiol; 2015 Mar; 183():155-61. PubMed ID: 25666125
[TBL] [Abstract][Full Text] [Related]
40. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
Dai DF; Hwang JJ; Lin JL; Lin JW; Hsu CN; Lin CM; Chiang FT; Lai LP; Hsu KL; Tseng CD; Tseng YZ
Circ J; 2008 Aug; 72(8):1316-23. PubMed ID: 18654020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
